What side effects do patients report most often with Entresto (sacubitril/valsartan)?
Patient reviews commonly mention side effects that match Entresto’s known risks, especially those tied to blood pressure and kidney function. The most frequently discussed include symptoms consistent with low blood pressure (dizziness or lightheadedness), and fatigue/weakness. Some reviews also describe kidney-related issues (reduced kidney function or rising creatinine) and electrolyte changes, which can feel like generalized tiredness or weakness.
Patients can also report gastrointestinal effects (like nausea) and headaches. Because Entresto affects blood vessels and hormone pathways, side effects in reviews often overlap with how patients feel day to day on heart failure therapy—energy level changes, exercise tolerance, and episodes of feeling “washed out,” especially early in treatment or after dose changes.
Why do patient reviews mention dizziness and feeling “lightheaded”?
Entresto lowers blood pressure. Reviews that mention dizziness are often describing treatment-related hypotension, particularly when starting therapy, during dose increases, or if the patient is also on other blood pressure-lowering drugs (common in heart failure care). This is also why clinicians usually monitor blood pressure and adjust doses to reduce symptomatic drops.
Do patients complain about kidney problems on Entresto?
Some patient reviews do reference lab-related concerns such as worse kidney numbers. Entresto can worsen kidney function in certain patients, especially when used with other medications that affect kidney blood flow or potassium balance. Patients may not always know the lab cause behind symptoms, but reviews can reflect that experience indirectly (for example, feeling weaker or noticing less tolerance for activity after a medication change).
Are potassium levels a common theme in Entresto side effect stories?
Entresto can increase potassium in some patients. If a review mentions muscle weakness, unusual fatigue, or “feeling off,” it may be related to electrolyte changes—though patients often attribute these symptoms broadly rather than to potassium specifically. Clinicians typically check potassium and kidney function regularly, especially early in treatment and after dose changes.
What side effects show up in reviews after starting or changing the dose?
A pattern that appears in patient accounts is that side effects are more noticeable at the start of therapy or after dose adjustments. Reviews frequently describe improvement after stabilization, because blood pressure and tolerance can settle over time. If side effects are severe or persistent, many patients describe contacting their prescriber for dose reduction or other medication changes.
What are the serious side effects patients watch for (even if less common in reviews)?
Some patient reviews also highlight warning signs that prompt medical attention, including:
- Symptoms of very low blood pressure (fainting or near-fainting)
- Signs of allergic reaction (swelling, hives, trouble breathing)
- Worsening kidney function symptoms in combination with significant weakness or confusion
These are not always detailed in reviews, but when patients do mention them, it’s usually because they sought urgent help or a rapid medication adjustment.
What patients often ask next: “Can I reduce side effects without stopping Entresto?”
Common real-world approaches that patients mention (or that prescribers typically consider) include dose timing adjustments, slower titration, reviewing other blood pressure medications, and closely monitoring labs. Patients who feel dizzy often ask whether they should take Entresto at a specific time of day or coordinate it with diuretics. Any changes should go through the prescriber because Entresto dosing and heart failure regimen changes can affect outcomes.
How do Entresto side effect reviews compare with lisinopril or other ACE inhibitors/ARBs?
Because Entresto is not the same class as lisinopril (an ACE inhibitor) or many ARBs, the side effect “mix” can differ. Patients who switch from an ACE inhibitor sometimes compare experiences around cough or angioedema risk (which is more specific to ACE inhibitors). Entresto can still cause low blood pressure and kidney/electrolyte issues, so dizziness and lab monitoring themes remain common across therapies.
If you want, tell me what specific side effects you’re noticing (e.g., dizziness, cough, swelling, fatigue), and whether you’re newly starting Entresto or adjusting the dose. I can help map those symptoms to the most likely categories patients discuss and what clinicians typically monitor.
Sources
- DrugPatentWatch.com – Entresto (sacubitril/valsartan) information